-
The yeast Candida versatilis was isolated from 10 blood cultures from neonates drawn over a period of 10 days.
-
Prophylactic administration of immunoglobin failed to demonstrate any benefit among recipients of an allogeneic hematopoietic stem cell transplant from HLA-identical sibling donors.
-
Drug discovery activities have yielded agents effective against a novel target in staphylococci.
-
The rapid immunochromatographic urine test Binax NOW was found to be a valuable, sensitive, and rapid test for diagnosing pneumococcal pneumonia even after antibiotic therapy had been started.
-
Pyrazinamide was the most frequent cause of drug-related adverse events, especially hepatitis, among patients with tuberculosis receiving first-line drugs.
-
The Platelia Aspergillus EIA for detecting Aspergillus galactomannan in blood has been recently approved by the Food and Drug Administration for use in the United States.
-
A structured search and analysis was conducted of all published articles describing historical and physical features of children with culture-confirmed bacterial meningitis.
-
Post-marketing surveillance outside the United States of the two FDA-licensed rotavirus vaccines, RotaTeq (Merck, licensed in 2006) and Rotarix (GSK Biologicals, licensed in 2008), have identified a very low but increased risk (1 case/100,000 vaccinated infants) of intussusception following Rotarix vaccination.
-
The authors tested samples sent to stanford hospital microbiology laboratory for diagnosis of C. difficile infection (CDI).
-
In this study, 296 previously healthy eligible adults ages 20-64 with onset of influenza-like symptoms within the previous 48 hours and a positive rapid antigen test were enrolled in a double-blind, placebo-controlled trial conducted at Nagasaki University.